Piper Sandler Remains Bullish on This Biotech Stock Amid Ongoing Selloff

Piper Sandler remains optimistic about a biotech stock amid a continuing market selloff. The firm’s analysts have identified potential in the stock, suggesting it could be a valuable investment opportunity despite the current turbulence in the biotech sector. They believe that long-term fundamentals and upcoming developments could drive the stock’s performance positively, attracting buyers even as market conditions fluctuate.